MedPath

Clinical Trial for Surgery of the Ulnar Nerve (SUN) at the Elbow

Not Applicable
Recruiting
Conditions
Neuropathy Ulnar
Interventions
Procedure: Simple decompression
Procedure: Subcutaneous anterior transposition
Registration Number
NCT04254185
Lead Sponsor
University of Michigan
Brief Summary

This research is studying two surgical procedures in a large group of people to learn about how well these procedures work as a treatment for ulnar neuropathy at the elbow (UNE). Researchers want to see which surgery is more helpful for people with ulnar neuropathy. This research will determine if one surgery is better than the other to alleviate symptoms.

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
378
Inclusion Criteria
  • A clinical diagnosis or suspected diagnosis of isolated ulnar neuropathy at the elbow
  • Confirmation of ulnar neuropathy using the American Association of Electrodiagnostic Medicine criteria for electrodiagnostic studies at the elbow. (Participants must meet at least 1 of the criteria to be enrolled (absolute motor nerve conduction from above elbow (AE) to below elbow (BE) of less than 50 m/s; An AE to BE segment greater than 10 m/s slower than BE to wrist segment; A decrease in compound muscle action potential (CMAP) negative peak amplitude from BE to AE greater than 20%)
  • Stated willingness to comply with all study procedures and availability for the duration of the study
  • Able to read, understand and complete the questionnaires in English
Read More
Exclusion Criteria
  • Previous elbow fracture requiring surgical fixation
  • Patients who have not attempted conservative management for UNE (e.g. night splinting)
  • Subluxation of ulnar nerve on preoperative exam
  • Recurrent UNE after previous surgery
  • Concomitant neuropathic conditions such as Carpal Tunnel Syndrome or cervical or brachial plexus abnormalities
  • Participants with severe comorbid conditions that prohibit surgery
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Simple decompressionSimple decompressionIn-situ decompression releases only the compressive ligamentous structures overlying the ulnar nerve.
Subcutaneous anterior transpositionSubcutaneous anterior transpositionAnterior transposition repositions the ulnar nerve, providing decompression and lengthening by moving the nerve anterior to the axis of elbow rotation
Primary Outcome Measures
NameTimeMethod
Effectiveness of surgery as measured by the Michigan Hand Outcomes Questionnaire (MHQ) summary score1 year

The MHQ is a self-report measure that assesses the function of the hand(s) and/or wrist(s). The MHQ contains six distinct scales assessing overall hand function, activities of daily living, pain, work performance, aesthetics and subject satisfaction with hand function. Scores range from 0-100, 100=no disability). In the pain scale, however, high scores indicate greater pain (0-100, 0=no pain).

Secondary Outcome Measures
NameTimeMethod
Recovery as measured by the Michigan Hand Outcomes Questionnaire (MHQ) pain scoreUp to 1 year

The MHQ is a self-report measure that assesses the function of hand(s) and/or wrist(s). The MHQ contains six distinct scales. The score will be measured at various time points to identify the recovery trend.In a pain scale, high scores indicate greater pain (0-100, 0=no pain)

Recovery as assessed by the Carpal tunnel questionnaire (CTQ) symptom scoreUp to 1 year

The CTQ (also known as the Levine Questionnaire, Boston Questionnaire, and the Brigham and Women's Questionnaire) contains 19 questions (11 symptom severity questions and 8 functional status questions). All questions use a scale of 1 to 5, with 1 being the best score or no symptoms.

The score will be measured at various time points to identify the recovery trend.

Recovery as assessed by the Carpal tunnel questionnaire (CTQ) pain scoreUp to 1 year

The CTQ (also known as the Levine Questionnaire, Boston Questionnaire, and the Brigham and Women's Questionnaire) contains 19 questions (11 symptom severity questions and 8 functional status questions). All questions use a scale of 1 to 5, with 1 being the best score or no symptoms.

The score will be measured at various time points to identify the recovery trend.

Difference in Pinch Strength (unaffected hand - affected hand) as measured by a pinch gaugeUp to 1 year

Pinch strength will be recorded, to the nearest half-kilogram. It will be measured at various time points to identify the recovery trend.

Difference in Grip Strength (unaffected hand - affected hand) measured by a Jamar dynamometerUp to 1 year

Measured in kilograms. Grip strength will be measured at various time points to identify the recovery trend.

Difference in distance assessed by the 2 Point Discrimination (unaffected hand - affected hand)Up to 1 year

Thresholds on the tip of the finger of both hands are assessed using the method of constant stimuli. One single needle and seven pairs of needles with different spacing's are tested in randomized order. After each presentation, the subject has to report the sensation of one or two needles by answering immediately "one" or "two." The threshold difference will be measured at various time points to identify the recovery trend.

Sensory difference as assessed by Semmes-Weinstein Monofilament test (unaffected hand - affected hand)Up to 1 year

A quantitative method to systematically assess the threshold stimulus necessary for perception of light touch to deep pressure by using monofilaments of different sizes.

Interpretation scale for monofilaments:

2.83 Normal 3.61 Diminished light touch 4.31 Diminished protective sensation 4.56 Loss of protective sensation 6.65 Deep pressure sensation only Sensory thresholds will be measured at various time points to identify the recovery trend.

Complication rates for both surgical procedures assessed using a checklistUp to 1 year

Complications will be categorized by type, severity, and frequency captured at Surgery, 2-Week, 6-Week, 3-Month, and 12 Month Visits.

Disease severity as measured by ulnar neuropathy at the elbow (UNE) severity scaleEnrollment, approximately day 0

Severity is determined based on responses to three parts sensory, motor, and test outcomes. Each part is scored 1-3, where 3=most disability.

Trial Locations

Locations (10)

Emory Healthcare

🇺🇸

Atlanta, Georgia, United States

Ohio State University

🇺🇸

Columbus, Ohio, United States

University of Pittsburgh Medical Center

🇺🇸

Pittsburgh, Pennsylvania, United States

Norton Healthcare

🇺🇸

Louisville, Kentucky, United States

Curtis National Hand Center

🇺🇸

Baltimore, Maryland, United States

Michigan Medicine

🇺🇸

Ann Arbor, Michigan, United States

Johns Hopkins University

🇺🇸

Baltimore, Maryland, United States

OrthoCarolina Research Institute, Inc.

🇺🇸

Charlotte, North Carolina, United States

University of Oklahoma

🇺🇸

Oklahoma City, Oklahoma, United States

Wake Forest University Health Sciences

🇺🇸

Winston-Salem, North Carolina, United States

© Copyright 2025. All Rights Reserved by MedPath